XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Common Stock Held in Treasury
Balance at beginning of period (shares) at Dec. 31, 2021   57,322       8,843
Balance at beginning of period at Dec. 31, 2021 $ 1,808,127 $ 573 $ 1,724,956 $ 866,679 $ (131,299) $ (652,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued under share-based compensation plan, net of 28 shares net-settled 0   (1,281)     $ 1,281
Shares issued under share-based compensation plan (shares)           (17)
Share-based compensation expense 3,075   3,075      
Net income 28,005     28,005    
Cash dividends (14,546)     (14,546)    
Currency translation adjustment 11,789       11,789  
Purchases of treasury stock (shares)           1,048
Purchases of treasury stock, including excise tax (72,217)         $ (72,217)
Balance at end of period (shares) at Mar. 31, 2022   57,322       9,874
Balance at end of period at Mar. 31, 2022 1,764,233 $ 573 1,726,750 880,138 (119,510) $ (723,718)
Balance at beginning of period (shares) at Dec. 31, 2021   57,322       8,843
Balance at beginning of period at Dec. 31, 2021 1,808,127 $ 573 1,724,956 866,679 (131,299) $ (652,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 173,429          
Balance at end of period (shares) at Sep. 30, 2022   57,322       10,861
Balance at end of period at Sep. 30, 2022 1,805,155 $ 573 1,732,500 995,669 (127,366) $ (796,221)
Balance at beginning of period (shares) at Mar. 31, 2022   57,322       9,874
Balance at beginning of period at Mar. 31, 2022 1,764,233 $ 573 1,726,750 880,138 (119,510) $ (723,718)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 2,875   2,875      
Net income 86,108     86,108    
Cash dividends (14,235)     (14,235)    
Currency translation adjustment (484)       (484)  
Purchases of treasury stock (shares)           301
Purchases of treasury stock, including excise tax (20,499)         $ (20,499)
Balance at end of period (shares) at Jun. 30, 2022   57,322       10,175
Balance at end of period at Jun. 30, 2022 1,817,998 $ 573 1,729,625 952,011 (119,994) $ (744,217)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 2,875   2,875      
Net income 59,316     59,316    
Cash dividends (15,658)     (15,658)    
Currency translation adjustment (7,372)       (7,372)  
Purchases of treasury stock (shares)           686
Purchases of treasury stock, including excise tax (52,004)         $ (52,004)
Balance at end of period (shares) at Sep. 30, 2022   57,322       10,861
Balance at end of period at Sep. 30, 2022 1,805,155 $ 573 1,732,500 995,669 (127,366) $ (796,221)
Balance at beginning of period (shares) at Dec. 31, 2022   57,322       11,030
Balance at beginning of period at Dec. 31, 2022 1,879,766 $ 573 1,734,528 1,060,603 (106,573) $ (809,365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued under share-based compensation plan, net of 28 shares net-settled (2,463)   (7,156)     $ 4,693
Shares issued under share-based compensation plan (shares)           (64)
Share-based compensation expense 3,375   3,375      
Net income 47,388     47,388    
Cash dividends (15,294)     (15,294)    
Currency translation adjustment 29,513       29,513  
Purchases of treasury stock (shares)           782
Purchases of treasury stock, including excise tax (71,411)         $ (71,411)
Balance at end of period (shares) at Mar. 31, 2023   57,322       11,748
Balance at end of period at Mar. 31, 2023 1,870,874 $ 573 1,730,747 1,092,697 (77,060) $ (876,083)
Balance at beginning of period (shares) at Dec. 31, 2022   57,322       11,030
Balance at beginning of period at Dec. 31, 2022 1,879,766 $ 573 1,734,528 1,060,603 (106,573) $ (809,365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 149,712          
Balance at end of period (shares) at Sep. 30, 2023   57,322       12,214
Balance at end of period at Sep. 30, 2023 1,917,584 $ 573 1,737,497 1,164,228 (64,521) $ (920,193)
Balance at beginning of period (shares) at Mar. 31, 2023   57,322       11,748
Balance at beginning of period at Mar. 31, 2023 1,870,874 $ 573 1,730,747 1,092,697 (77,060) $ (876,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 3,375   3,375      
Net income 45,180     45,180    
Cash dividends (15,298)     (15,298)    
Currency translation adjustment 27,802       27,802  
Purchases of treasury stock (shares)           371
Purchases of treasury stock, including excise tax (35,214)         $ (35,214)
Balance at end of period (shares) at Jun. 30, 2023   57,322       12,119
Balance at end of period at Jun. 30, 2023 1,896,719 $ 573 1,734,122 1,122,579 (49,258) $ (911,297)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 3,375   3,375      
Net income 57,144     57,144    
Cash dividends (15,495)     (15,495)    
Currency translation adjustment (15,263)       (15,263)  
Purchases of treasury stock (shares)           95
Purchases of treasury stock, including excise tax (8,896)         $ (8,896)
Balance at end of period (shares) at Sep. 30, 2023   57,322       12,214
Balance at end of period at Sep. 30, 2023 $ 1,917,584 $ 573 $ 1,737,497 $ 1,164,228 $ (64,521) $ (920,193)